NCT04857502View on ClinicalTrials.gov

99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2027

Conditions
Prostate CarcinomaRecurrent Prostate Carcinoma
Interventions
DRUG

99mTc-based PSMA Imaging and Surgery Agent

Given via IV injection

PROCEDURE

Computed Tomography

Undergo SPECT/CT

PROCEDURE

Single Photon Emission Computed Tomography

Undergo SPECT/CT

Trial Locations (1)

90095

RECRUITING

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER